Pro and contra of specific hyposensitization

European Journal of Dermatology

Volumn 9, Issue 4, 1999, Pages 325-331

  Karl, Sonja ^a   Ring, Johannes ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Allergen extracts; Anaphylaxis; IgE mediated allergy; Oral hyposensitization; Side effects; Specific hyposensitization

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G;

ALLERGIC REACTION; ANAPHYLAXIS; ATOPY; CARDIOVASCULAR DISEASE; DESENSITIZATION; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNOTHERAPY; INTRANASAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; RESPIRATORY TRACT DISEASE; REVIEW; SKIN MANIFESTATION; SUBCUTANEOUS DRUG ADMINISTRATION; SUBLINGUAL DRUG ADMINISTRATION; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

EID: 0032974014     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Elliot JR, Middleton MD, Charles E, Reed MD. Allergy: principles and practice. Mosby St Louis, 4th edition, 1993.
2. Ring J. Angewandte Allergologie. 2. Auflage, 1991, MMV Medizin Verlag, München.
3. Noon L. Prophylactic inoculation against hay-fever. Lancet 1911 ; 1572.
4. Freeman EJ. Vaccination against hay-fever. Lancet 1178: 1914/1.
5. Durham S, Varney V, Gaga M, Frew A, Jacobson M, Kay A. Immunotherapy and allergic inflammation. Clin Exp Allergy 1991; 21 (suppl. 1): 206-10.
6. Malling H, Weeke B. Immunotherapy. Position paper of the European Academy of Allergy and clinical immunology. Allergy 1993; 48 (suppl. 14): 9-35.
7. Ring J, Przybilla B, Bongardts J. Safety of hyposensitization. Proceedings Annual Meeting of the E.A.A.C.I. Mallorca 87, 22-26th April Palma de Mallorca, Spain, 1987; 130-8.
8. Nelson HS, Ikle D, Buchmeier A. Studies of allergen extract stability: the effects of dilution and mixing. J Allergy Clin Immunol 1996; 98: 382-8.
9. Ortolani C, Pastorello E, Moss RB. Grass pollen immunotherapy: a single year double-blind, placebo-controlled study in patients with grass pollen-induced asthma and rhinitis. J Allergy Clin Immunol 1984; 73: 283-90.
10. Rak S, Hakansson L, Venge P. Eosinophil chemotactic activity in allergic patients during the birch pollen season; the effect of immunotherapy. Int Arch Allergy Appl Immunol 1987; 82: 349-50.
11. Warner JO, Price JF, Soothill JF, Hey EN. Controlled trial of hyposensitisation to dermatophgagoides pteronyssinus in children with asthma. Lancet 1978; 2: 912-5.
12. Van Bever HP, Stevens WJ: Evolution of the late asthmatic reaction during immunotherapy and after stopping immunotherapy. J Allergy Clin Immunol 1990; 86: 141-6.
13. Zachariae H, Cramers M, Herlin T, Jensen J, Kragbaly K, Ternowitz T, Thestrup-Petersen K. Non-specific immunotherapy and specific hyposensitization in severe atopic dermatitis. Acta derm-venereol (Stockh.), 1985; (suppl. 114): 48-54.
14. Ring J. Successful hyposensitization treatment in atopic dermatitis; results of a trial in monozygotic twins. Brit J Dermatol 1982; 107: 597-602.
15. Horst M, Hejjaoui A, Horst V, Michel FB, Bousquet J. Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract. J Allergy Clin Immunol 1990; 85: 460-72.
16. Malling HJ, Dreborg S, Weeke B. Diagnosis and immunotherapy of mold allergy. V. Clinical efficacy and side effects of immunotherapy with Cladosporium herbarum. Allergy 1986; 41: 507-19.
17. Alvarez-Cuesta E, Cuesta-Herranz J, Puyana-Ruiz J, Cuesta-Herranz C, Blanco-Quiros A. Monoclonal antibody-standardized cat extract immunotherapy: risk-benefit effects from a double-blind placebo study. J Allergy Clin Immunol 1994; 93: 556-66.
18. Ring J. Spezifische Hyposensibilisierung. Wirkungsmechanismen, Erfolge und Probleme. Allergologie 1987; 10: 392-403.
19. Kiehn M, Ring J. Hyposensibilisierung mit Insektengiftextrakten bei Patienten mit Hymenopterengift-Allergie im höheren Lebensalter. Allergo J 1993; 2 (suppl.): 90-4.
20. Jacobson L, Dreborg S, Moller C. Immunotherapy as a preventive treatment. J Allergy Clin Immunol 1996; 97: 232.
21. Barnard J. Studies of 400 hymenoptera sting deaths. J Allergy Clin Immunol 1973; 52: 259-64.
22. Ownby DR, Adinoff AD: The appropriate use of skin testing and allergen immunotherapy in young children. J Allergy Clin Immunol 1994; 94: 662-5.
23. Georgitis JW, Nickelsen JA, Wypych JI Barde SH, Clayton WF, Reisman RE. Local nasal immunotherapy with high-dose polymerized ragweed extract. Int Archs Allergy appl Immun 1986; 81: 170-3.
24. Passalacqua G, Albano M, Fregonese L, Riccio A, Pronzato C, Mela GS, Canonica GW. Randomised controlled trial in local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis. Lancet 1998; 351: 613-4.
25. Passalacqua G, Canonica GW. Alternative routes for allergen-specific immunotherapy. J Invest Allergol clin Immunol 1996; 6: 81-7.
26. Klepzig K, Ring J, Burg G. Pseudolymphom nach Hyposensibilisierung. Allergologie 1987; 10: 432.
27. Przybilla B, Ring J, Grießhammer J, Braun-Falco O. Schnellhyposensibilisierung mit Hymenopterengiften-Verträglichkeit und Therapieerfolg. Dtsch med Wschr 1987; 112: 416-24.
28. Phanuphak P, Kohler PF. Onset of polyarteritis nodosa during allergic hyposensitization treatment. Amer J Med 1980; 68: 479-85.
29. Berbis Ph, Carena MC, Auffranc JC, Privat Y. Vascularite nécrosante cutanéo-systémique survenue en course de désensibilisation. A Derm Venereol 1986; 113: 805-9.
30. Wüthrich B. Zur spezifischen Hyposensibilisierung der Pollinosis. Schweiz Rundsch Med 1977; 66: 260.
31. Rakoski J, v. Mayenburg J, Lagally G. Untersuchungen zum Risiko der spezifischen Hyposensibilisierungsbehandlung mit Inhalationsallergenen und Insektengiften. Doppelinjektionen und Einzelinjektionen. Allergologie 1986; 9: 398-401.
32. Frankland AW. Anaphylactic reactions to desensitization. Br Med J 1980; 281: 1429.
33. Lockey RF, Benedict LM, Turkeltaub PC, Bukantz SC. Fatalities from immunotherapy (IT) and skin testing (ST). J Allergy Clin Immunol 1987; 79: 660-77.
34. Reid MJ, Lockey RF, Turkeltaub PC, Platts-Mills TA. Survey of fatalities from skin testing and immunotherapy 1985-1989. J Allergy Clin Immunol 1993; 92: 6-15.
35. Djurup R, Malling HJ. High IgG 4 antibody level is associated with failure of immunotherapy with inhalant allergens. Clin Allergy 1987; 17: 459-68.
36. Jung CM, Prinz JC, Rieber EP, Ring J. A reduction in allergen-induced Fc epsilon R2/CD 23 expression on peripheral B cells correlates with successful hyposensitization in grass pollinosis. J Allergy Clin Immunol 1995; 95: 77-87.
37. Carballido JM, Carballido-Perrig N, Terres G, Heusser CH, Blaser K. Bee venom phospholipase A2-specific T-cell clones from human allergic and non-allergic individuals: cytokine patterns change in response to the antigen concentration. Eur J Immunol 1992; 22: 1357-63.
38. Carballido JM, Carballido-Perrig N, Oberli-Schrammli A, Heusser CH, Blaser K. Regulation of IgE and IgG4 responses by allergen specific T-cells clones to bee venom phospholipase A2 in vitro. J Allergy Clin Immunol 1994; 93: 758-67.